Chemsphere Technology Inc.
|
Midostaurin is a multi-targeted protein kinase inhibitor that has been investigated for the treatment of acute myeloid leukemia (AML), myelodysplastic syndrome (MDS) and advanced systemic mastocytosis. It is a semi-synthetic derivative of staurosporine, an alkaloid from the bacterium Streptomyces staurosporeus. |
Send Inquiry
|
Sichuan Chenghua Bio-technology Co., Ltd.
|
Business scope includes medical research and experimental development; Medical research, technology development, technology transfer and technical services (excluding medical and health activities); Research and development of medical devices and experimental devices; Production (limited to branch offices operating at another site) and sales: chemical products and raw materials (excluding dangerous chemicals, monitoring chemicals and precursor chemicals) |
Send Inquiry
|